Provided by Tiger Trade Technology Pte. Ltd.

Connect Biopharma Holdings Ltd.

2.30
-0.0650-2.75%
Volume:202.66K
Turnover:467.54K
Market Cap:144.50M
PE:-1.92
High:2.37
Open:2.36
Low:2.26
Close:2.36
52wk High:3.82
52wk Low:1.23
Shares:62.96M
Float Shares:21.07M
Volume Ratio:0.78
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1933
EPS(LYR):-1.0000
ROE:-140.51%
ROA:-69.75%
PB:5.38
PE(LYR):-2.29

Loading ...

Connect Biopharma initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
May 21

Connect Biopharma files to sell 6.13M ordinary shares for holders

TIPRANKS
·
May 15

Connect Biopharma Holdings Ltd - Proposed Resale of up to 6.1 Mln Ordinary Shares of Connect Biopharma - SEC Filing

THOMSON REUTERS
·
May 15

Connect Biopharma posts corporate presentation on rademikibart development in asthma, COPD, atopic dermatitis

Reuters
·
May 14

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright

TIPRANKS
·
May 13

Connect Biopharma Hldgs Q1 EPS $(0.34) Misses $(0.28) Estimate, Sales $169.000K

Benzinga Earnings
·
May 12

Connect Biopharma Holdings Ltd: Currently Remain on Track to Report Topline Results From Both Seabreeze Stat Studies Mid-Year

THOMSON REUTERS
·
May 12

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
May 12

Simcere says China regulator accepts NDA for atopic dermatitis drug rademikibart

Reuters
·
Apr 30

Northland Securities Remains a Buy on Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 24

Connect Biopharma Holdings Ltd - Expects to Report Phase 2 Seabreeze Stat Topline Data in Mid-2026

THOMSON REUTERS
·
Apr 23

Connect Biopharma Holdings: Data Monitoring Committee Reports No Safety Concerns or Treatment-Related Serious Adverse Events in Seabreeze Stat Studies

THOMSON REUTERS
·
Apr 23

Connect Biopharma Holdings - Enrollment in Phase 2 Seabreeze Stat Studies Will Continue as Planned Following Pre-Specified Interim Analysis

THOMSON REUTERS
·
Apr 23

Connect Biopharma Seabreeze STAT Phase 2 trials continue unchanged after interim review

Reuters
·
Apr 23

Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Apr 08

Connect Biopharma Price Target Maintained With a $10.00/Share by BTIG

Dow Jones
·
Apr 02

Connect Biopharma director James Huang acquires $4 million common shares

Reuters
·
Apr 02

Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Apr 01

Connect Biopharma Hldgs Q4 EPS $(0.27) Beats $(0.30) Estimate

Benzinga Earnings
·
Apr 01